Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP256276.RA9tni1c9-DVniBbI2wkxB_4JZPyvgojP0ruDaAmKRtoM130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256276.RA9tni1c9-DVniBbI2wkxB_4JZPyvgojP0ruDaAmKRtoM130_provenance.
• NP934802.RAAc-BT26UtlqOSQ21QFATsM74F6apfz83CFNwPYOpLEk130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP934802.RAAc-BT26UtlqOSQ21QFATsM74F6apfz83CFNwPYOpLEk130_provenance.
• NP787115.RAjUvl4cPtmnUNwEkdc8_RTNZvfR85RHbuFnMkwsGmiFo130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP787115.RAjUvl4cPtmnUNwEkdc8_RTNZvfR85RHbuFnMkwsGmiFo130_provenance.
• NP290654.RARu3FsmKl6knnfVROdu9u8Dgj8uq7lbW9_sHcEdAHZ8Y130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP290654.RARu3FsmKl6knnfVROdu9u8Dgj8uq7lbW9_sHcEdAHZ8Y130_provenance.
• assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP672501.RA5xDCsK45zFb3ptaRfTK2uUHEKxRsyGDssMIAZW2i3b0130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP672501.RA5xDCsK45zFb3ptaRfTK2uUHEKxRsyGDssMIAZW2i3b0130_provenance.
• NP741123.RA1PQg6JFZEXiNa5va9Hi_NzIkVPE1Ue58IfrmhlWYtgk130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP741123.RA1PQg6JFZEXiNa5va9Hi_NzIkVPE1Ue58IfrmhlWYtgk130_provenance.
• NP642217.RAUjldIvNEpgjrgyjSUW8Y37_MG2EGcWt1sgtYMFRan6M130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP642217.RAUjldIvNEpgjrgyjSUW8Y37_MG2EGcWt1sgtYMFRan6M130_provenance.
• NP838389.RAacdza3HYtkt75NB0zeYVUWKtb-9QU8T7UBaj1-VyAt8130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP838389.RAacdza3HYtkt75NB0zeYVUWKtb-9QU8T7UBaj1-VyAt8130_provenance.
• NP501954.RAI-6Ix5q7oft5MYo00uxQjnxu2CzwTu9N_uMQn1akd5k130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501954.RAI-6Ix5q7oft5MYo00uxQjnxu2CzwTu9N_uMQn1akd5k130_provenance.
• NP591387.RAJcynfnM3d2jLdiGF_bJ3hxJQGJ0_n_A8htY1jCmKkb0130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591387.RAJcynfnM3d2jLdiGF_bJ3hxJQGJ0_n_A8htY1jCmKkb0130_provenance.
• NP282827.RAu5fqcZtM9wkLlVj_onQZLwLg02kqW-gupYfREbUvdew130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP282827.RAu5fqcZtM9wkLlVj_onQZLwLg02kqW-gupYfREbUvdew130_provenance.
• NP1065381.RARsmQrsVnZFuIYFxSdkS2OyrvGEzWm4MQsfj2941N-Io130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1065381.RARsmQrsVnZFuIYFxSdkS2OyrvGEzWm4MQsfj2941N-Io130_provenance.
• NP1065386.RAaD-fpTxu9NQi_UtMgBu8KZcvLfEDbD0U8m0FzIpV47I130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1065386.RAaD-fpTxu9NQi_UtMgBu8KZcvLfEDbD0U8m0FzIpV47I130_provenance.
• NP1065387.RAAXY5LBHqoI9r7dgqcBnqMlRCcqv__HSBe9LKROxNw7g130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1065387.RAAXY5LBHqoI9r7dgqcBnqMlRCcqv__HSBe9LKROxNw7g130_provenance.
• NP252567.RAj6KrwpMMPLDqmwWAYl9yFNkefRqhOtCiYl1Wxv-XB7Y130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP252567.RAj6KrwpMMPLDqmwWAYl9yFNkefRqhOtCiYl1Wxv-XB7Y130_provenance.
• NP866493.RAOUqg0-KbVvs0fvLMt3Zm2Cwn7A-QpVrkWqKU3svaw1c130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP866493.RAOUqg0-KbVvs0fvLMt3Zm2Cwn7A-QpVrkWqKU3svaw1c130_provenance.
• NP1065380.RAs2yCDngaZeHDPky1D_hJJ3fCTnE3EekSCljjk61vX5E130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1065380.RAs2yCDngaZeHDPky1D_hJJ3fCTnE3EekSCljjk61vX5E130_provenance.
• NP1065382.RAhy-8oLvmk-tcBfZfKj6IcIFaXeghG0te3iKfCNZarIM130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1065382.RAhy-8oLvmk-tcBfZfKj6IcIFaXeghG0te3iKfCNZarIM130_provenance.
• NP1065385.RArmOqFujljFwaA7gPkw5nUaUbOhmeJqL1uwfcjSq5-yU130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1065385.RArmOqFujljFwaA7gPkw5nUaUbOhmeJqL1uwfcjSq5-yU130_provenance.
• NP338540.RA-wmgLizSHGIjo2akVhE5QbjNrvg14JV0NdSZPrcLUE8130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP338540.RA-wmgLizSHGIjo2akVhE5QbjNrvg14JV0NdSZPrcLUE8130_provenance.
• NP710123.RAIuzVL_DHQ_VYzdn3nRBXWN5O4Fe6iIGQRVXYxAAo6Kg130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710123.RAIuzVL_DHQ_VYzdn3nRBXWN5O4Fe6iIGQRVXYxAAo6Kg130_provenance.
• NP1065388.RAPswPzUtYWe1rnuJzhvgPS2WIelg-FiY3gUGvqS0qw8A130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1065388.RAPswPzUtYWe1rnuJzhvgPS2WIelg-FiY3gUGvqS0qw8A130_provenance.
• NP833712.RA49JcHm4k5sI-EB669ni-vIiynq1yc_qQwb1fFdqnlvU130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP833712.RA49JcHm4k5sI-EB669ni-vIiynq1yc_qQwb1fFdqnlvU130_provenance.
• NP1005030.RAzL5iqacnxPpDtExaCsSEdOlkL7ydlHpss8Ol9EpDGLg130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1005030.RAzL5iqacnxPpDtExaCsSEdOlkL7ydlHpss8Ol9EpDGLg130_provenance.
• NP1065383.RA56MhwdCYIGKdGMUAPz2wG1xedzGeBwfJ5-9xFuc_lQg130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1065383.RA56MhwdCYIGKdGMUAPz2wG1xedzGeBwfJ5-9xFuc_lQg130_provenance.
• NP1065384.RA4hcqjSiBTYTvtDvGZtODepgRcvzq74WeB2J0WYzze14130_assertion description "[Effective clinical treatment with anti-CD19 CAR T cells was first reported in 2010 after a patient with advanced-stage lymphoma treated at the NCI experienced a partial remission of lymphoma and long-term eradication of normal B cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1065384.RA4hcqjSiBTYTvtDvGZtODepgRcvzq74WeB2J0WYzze14130_provenance.